ReproCELL Incorporated's latest marketcap:
As of 07/28/2025, ReproCELL Incorporated's market capitalization has reached $138.12 M. According to our data, ReproCELL Incorporated is the 22687th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 138.12 M |
| Revenue (ttm) | 20.11 M |
| Net Income (ttm) | 695,616.94 |
| Shares Out | 94.69 M |
| EPS (ttm) | 0.01 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
ReproCELL Incorporated's yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ¥20.45 B | $138.12 M | 117.4% | 22687 |
| 12/30/2024 | ¥9.8 B | $62.33 M | -34.19% | 26442 |
| 12/29/2023 | ¥14.89 B | $105.57 M | -42.13% | 22670 |
| 12/30/2022 | ¥25.73 B | $196.07 M | 35.26% | 18134 |
| 12/30/2021 | ¥19.02 B | $165.31 M | -35.21% | 19978 |
| 12/30/2020 | ¥29.36 B | $284.21 M | 94.87% | 14866 |
| 12/30/2019 | ¥15.07 B | $138.77 M | 11% | 16476 |
| 12/28/2018 | ¥13.57 B | $123.79 M | -33.21% | 16206 |
| 12/29/2017 | ¥20.32 B | $180.28 M | -18.63% | 15076 |
| 12/30/2016 | ¥24.98 B | $213.55 M | 21.08% | 12534 |
Company Profile
About ReproCELL Incorporated
ReproCELL Incorporated is a Japan-based company specializing in stem cell research and drug discovery services. Founded in 2003 and headquartered in Yokohama, the company supports advancements in biotechnology and pharmaceutical research.
Products & Services
ReproCELL offers a comprehensive range of solutions for stem cell research and drug development, including:
- Stem Cell Reagents: RNA reprogramming, small molecules, growth factors, cytokines, antibodies, staining kits, and more.
- Differentiated iPSC & Related Reagents: Feeder cells, pluripotent stem cells, and synfire induced neurons.
- 3D Cell Culture & Labware: Advanced tools for cell culture applications.
- Research & Testing Services: Genomics, clinical stem cell research, preclinical CRO, precision medicine, and gene editing.
- Human Tissue Samples & Diagnostics: High-quality biospecimens and clinical laboratory services.
With a strong focus on innovation, ReproCELL supports researchers and pharmaceutical companies in accelerating drug discovery and regenerative medicine.
Frequently Asked Questions
-
What is ReproCELL Incorporated's (TYO-4978) current market cap?As of 07/28/2025, ReproCELL Incorporated (including the parent company, if applicable) has an estimated market capitalization of $138.12 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ReproCELL Incorporated (TYO-4978) rank globally by market cap?ReproCELL Incorporated global market capitalization ranking is approximately 22687 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.